AlphaStocks

DGX vs MD

As of Sep 20, 2026, Quest Diagnostics (DGX) scores 6.8/10 and Pediatrix Medical Group (MD) 6.9/10 on AlphaStocks' five-model composite, so MD scores higher. DGX trades 24% above its model fair value; MD trades 25% below its model fair value.

DGX

QUEST DIAGNOSTICS INC

6.8

Consider Buy

$246.52

MD

Pediatrix Medical Group, Inc.

6.9

Consider Buy

$25.93

DGX vs MD: Which is the Better Investment?

QUEST DIAGNOSTICS INC (DGX) scores 6.8/10 while Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' composite model. Pediatrix Medical Group, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Pediatrix Medical Group, Inc. trades at 13.4x, making it the more attractively priced of the two. Pediatrix Medical Group, Inc. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricDGXMD
Scores & Fundamentals
Composite Score6.8/106.9/10
RatingConsider BuyConsider Buy
Price$246.52$25.93
P/E Ratio28.113.4
ROE13.8%18.8%
Market Cap$28B$2B
Fair Value$199.57$34.74
Dividend Yield1.5%
Sector Rank#19 of 168#17 of 168
Model Verdicts
PiotroskiStrongAttractive
BuffettAttractiveAttractive
GrahamCautionCaution
LynchNeutralNeutral
GreenblattAttractiveStrong
View full DGXanalysis →View full MDanalysis →

Related comparisons

Compare any two stocks →

DGX vs MD: Which Stock Scores Higher?

QUEST DIAGNOSTICS INC (DGX) and Pediatrix Medical Group, Inc. (MD) are both in the Health Care sector. MD currently leads with a composite score of 6.9/10 (Consider Buy) compared to DGX's 6.8/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer